Bank of New York Mellon Corp cut its position in shares of USANA Health Sciences, Inc. (NYSE:USNA) by 57.9% during the first quarter, Holdings Channel reports. The fund owned 79,523 shares of the company’s stock after selling 109,147 shares during the period. Bank of New York Mellon Corp’s holdings in USANA Health Sciences were worth $4,580,000 at the end of the most recent reporting period.
Other hedge funds have also added to or reduced their stakes in the company. Russell Investments Group Ltd. acquired a new stake in USANA Health Sciences during the fourth quarter worth about $1,535,000. AQR Capital Management LLC raised its stake in USANA Health Sciences by 56.7% in the fourth quarter. AQR Capital Management LLC now owns 52,024 shares of the company’s stock worth $3,184,000 after buying an additional 18,814 shares during the last quarter. Teachers Advisors LLC raised its stake in USANA Health Sciences by 137.7% in the fourth quarter. Teachers Advisors LLC now owns 217,677 shares of the company’s stock worth $13,322,000 after buying an additional 126,090 shares during the last quarter. Norges Bank acquired a new stake in USANA Health Sciences during the fourth quarter worth about $6,855,000. Finally, State Street Corp raised its stake in USANA Health Sciences by 104.3% in the fourth quarter. State Street Corp now owns 190,838 shares of the company’s stock worth $11,676,000 after buying an additional 97,430 shares during the last quarter. Institutional investors own 44.26% of the company’s stock.
Shares of USANA Health Sciences, Inc. (NYSE:USNA) opened at 63.45 on Monday. USANA Health Sciences, Inc. has a one year low of $52.55 and a one year high of $75.00. The stock has a market capitalization of $1.56 billion, a price-to-earnings ratio of 16.02 and a beta of 1.13. The company’s 50 day moving average price is $64.52 and its 200 day moving average price is $60.84.
USANA Health Sciences (NYSE:USNA) last announced its quarterly earnings results on Tuesday, May 2nd. The company reported $0.91 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.92 by $0.01. USANA Health Sciences had a net margin of 9.71% and a return on equity of 31.84%. The firm had revenue of $255.32 million during the quarter. On average, analysts expect that USANA Health Sciences, Inc. will post $3.95 earnings per share for the current fiscal year.
USNA has been the subject of a number of research analyst reports. BidaskClub lowered USANA Health Sciences from a “buy” rating to a “hold” rating in a report on Tuesday, June 20th. Zacks Investment Research upgraded USANA Health Sciences from a “sell” rating to a “hold” rating in a report on Wednesday, April 12th. Finally, Pivotal Research restated a “hold” rating and issued a $55.00 target price (down previously from $75.00) on shares of USANA Health Sciences in a report on Monday, May 1st.
In related news, Director Myron W. Wentz sold 40,000 shares of the business’s stock in a transaction on Monday, May 1st. The shares were sold at an average price of $56.39, for a total value of $2,255,600.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Gilbert A. Fuller sold 4,884 shares of the business’s stock in a transaction on Thursday, May 11th. The shares were sold at an average price of $64.38, for a total transaction of $314,431.92. Following the completion of the sale, the director now directly owns 4,884 shares in the company, valued at $314,431.92. The disclosure for this sale can be found here. Insiders sold a total of 134,735 shares of company stock valued at $8,371,021 in the last three months. 53.20% of the stock is owned by company insiders.
About USANA Health Sciences
USANA Health Sciences, Inc develops and manufactures science-based nutritional and personal care products. The Company operates as a direct selling company in two geographic regions: Americas and Europe, and Asia Pacific, which includes three sub-regions: Southeast Asia Pacific, Greater China and North Asia.
Want to see what other hedge funds are holding USNA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for USANA Health Sciences, Inc. (NYSE:USNA).
This story was originally published by WKRB News (https://www.wkrb13.com) and is the sole property of WKRB News. If you are reading this article on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. You can view the original version of this story at https://www.wkrb13.com/markets/2284336/bank-of-new-york-mellon-corp-has-4-58-million-position-in-usana-health-sciences-inc-usna.html
Receive News & Ratings for USANA Health Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for USANA Health Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.